Drawing for ACCELERA PHARMA

USPTO serial 79413602

ACCELERA PHARMA

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
OSGOOD, KRYSTINA E
Law office
TMO LAW OFFICE 121

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ACCELERA PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James A. Sheridan

James A. Sheridan Sheridan Law, LLC14343 Denver West ParkwaySuite 100Golden, CO 80401

Goods and services

ClassDescriptionStatusFirst use
035Advertising services relating to pharmaceuticals; advertising services relating to pharmaceutical products; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; advertising services in the field of pharmaceuticals; retail and wholesale store services featuring diagnostic pharmaceutical products and diagnostic substances for medical use; retail and wholesale store services featuring pharmaceuticals, medical and veterinary preparations; retail and wholesale store services featuring medicines; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring pharmaceuticals; retail and wholesale store services featuring pharmaceuticals.ACTIVE—
044Provision of medical information in the field of pharmacological treatment; provision of medical information relating to drugs; medical drug information services; medical consultancy relating to pharmaceutical and medical products; medical advisory services relating to pharmaceuticals; medical consultancy and information services relating to pharmaceutical products; medical consultancy and information services in the field of pharmaceutical.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 23, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 18, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 1, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 31, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 23, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 23, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Dec 23, 2025CNSLSUSPENSION LETTER WRITTEN—
Dec 3, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 3, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 3, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 21, 2025RFNTREFUSAL PROCESSED BY IB—
Jun 5, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 5, 2025RFRRREFUSAL PROCESSED BY MPU—
Apr 2, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 1, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2025DOCKASSIGNED TO EXAMINER—
Jan 3, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 3, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 2, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance